Diabetic Retinopathy, Teleretinal Imaging & The Artificial Intelligence Future

1. Diabetic Retinopathy is the leading cause of significant vision loss and new blindness in adults.

a) True
b) False

2. The prevalence rate for diabetic retinopathy in the American Indian (AI) and Alaska Native (AN) population is the highest for patients with an A1C >8%, who have had diabetes for >10 years, and are currently on insulin.

a) True
b) False

3. Diabetic macular edema causes fluid in the center of the retina and is one cause of vision loss in patients with diabetes.

a) True
b) False

4. The cause(s) of diabetic retinopathy include:

a) Lack of blood flow
b) Factor release from blood vessels
c) Small blood vessels are damaged
d) All of the above

5. JVN cameras no longer require dilation for use.

a) True
b) False

6. The treatment for non-proliferative diabetic retinopathy include(s):

a) Lowering A1C levels
b) Lowering blood pressure and lipid levels
c) Repeat dilated eye examinations or JVN
d) All of the above

7. The two types of diabetic retinopathy include non-proliferative and proliferative.

a) True
b) False

8. The treatment for proliferative diabetic retinopathy include(s):

a) Laser treatment
b) Anti-Vegf injections
c) All of the above

9. The IHS-JVN goals of incorporating the use of AI include developing an algorithm specific to the AI/AN patient population that can predict the 3 to 5-year risk of progression.

a) True
b) False